2021 Industry Partner Support
EFF would like to thank the following industry partners for supporting our 2021 educational programming.
- AstraZeneca for unrestricted grants for the Seventh Annual Forum on Diabetes, Obesity, and Metabolism
- Medtronic for unrestricted grants for the Seventh Annual Forum on Diabetes, Obesity, and Metabolism
- Amgen for unrestricted grants for the Metabolic Bone Disease Preceptorship at Columbia University
- Radius for unrestricted grants for the Metabolic Bone Disease Preceptorship at Columbia University
- Amgen for unrestricted grants for the EFF and ASBMR Fellows Forum on Metabolic Bone Diseases
- ASBMR for unrestricted grants for the EFF and ASBMR Fellows Forum on Metabolic Bone Diseases
- NIAMS for unrestricted grants for the EFF and ASBMR Fellows Forum on Metabolic Bone Diseases
- AstraZeneca for unrestricted grants for the Endocrine Fellows Research Grant Program
- Medtronic for unrestricted grants for the Endocrine Fellows Research Grant Program
- Merck & Co. for unrestricted grants for the Endocrine Fellows Research Grant Program
Endocrine Fellows Foundation
Our Vision
Our Goals
EFF Programs
Diabetes Research Forum
Diabetes Mellitus Preceptorship
Metabolic Bone Disease Preceptorship
Forum on Metabolic Bone Diseases
Get Connected with the EFF Community!
Fellows Spotlight
Congratulations to Dr. Coch for the publication of her EFF-funded study in the American Diabetes Association's Diabetes Journal. The Limited Role of Glucagon for Ketogenesis During Fasting or in Response to SGLT2 Inhibition Additionally she is starting a pilot study of glucagon infusion in dogs at the Cornell Veterinary School and hopes to repeat the study in humans at Weill-Cornell Medical School in the coming years.
Fellows Spotlight
Dr. Joseph Kindler has accepted a tenure-track Assistant Professor position in the Department of Foods and Nutrition at the University of Georgia (Athens, Georgia USA). In this role, Dr. Kindler will teach undergraduate and graduate level courses in nutrition, and will continue his clinical and translational research program involving determinants of peak bone mass. Notably, he intends to build upon his American Diabetes Association and Endocrine Fellows Foundation-funded research aimed at understanding the influence of type 2 diabetes on the growing skeleton. Click here to read more about Dr. Kindler's work.
.jpg)